FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381599128> ?p ?o ?g. }

• W4381599128 endingPage "1175" @default.
• W4381599128 startingPage "1159" @default.
• W4381599128 abstract "Ectopic pregnancy is an important health condition which affects up to 1 in 100 women. Women who present with mild symptoms and low serum human chorionic gonadotrophin (hCG) are often treated with methotrexate (MTX), but expectant management with close monitoring is a feasible alternative. Studies comparing the two treatments have not shown a statistically significant difference in uneventful resolution of ectopic pregnancy, but these studies were too small to define whether certain subgroups could benefit more from either treatment.We performed a systematic review and individual participant data meta-analysis (IPD-MA) of randomized controlled trials comparing systemic MTX and expectant management in women with tubal ectopic pregnancy and low hCG (<2000 IU/L). A one-stage IPD-MA was performed to assess overall treatment effects of MTX and expectant management to generate a pooled intervention effect. Subgroup analyses and exploratory multivariable analyses were undertaken according to baseline serum hCG and progesterone levels. Primary outcome was treatment success, defined as resolution of clinical symptoms and decline in level of serum hCG to <20 IU/L, or a negative urine pregnancy test by the initial intervention strategy, without any additional treatment. Secondary outcomes were need for blood transfusion, surgical intervention, additional MTX side-effects and hCG resolution times.PROSPERO: CRD42021214093.1547 studies reviewed and 821 remained after duplicates removed. Five studies screened for eligibility and three IPD requested. Two randomized controlled trials supplied IPD, leading to 153 participants for analysis. Treatment success rate was 65/82 (79.3%) after MTX and 48/70 (68.6%) after expectant management (IPD risk ratio [RR] 1.16, 95% confidence interval [CI] 0.95-1.40). Surgical intervention rates were not significantly different: 8/82 (9.8%) vs 13/70 (18.6%) (RR 0.65, 95% CI 0.23-1.14). Mean time to success was 19.7 days (95% CI 17.4-22.3) after MTX and 21.2 days (95% CI 17.8-25.2) after expectant management (P = 0.25). MTX specific side-effects were reported in 33 MTX compared to four in the expectant group.Our IPD-MA showed no statistically significant difference in treatment efficacy between MTX and expectant management in women with tubal ectopic pregnancy with low hCG. Initial expectant management could be the preferred strategy due to fewer side-effects." @default.
• W4381599128 created "2023-06-23" @default.
• W4381599128 creator A5008499634 @default.
• W4381599128 creator A5018646147 @default.
• W4381599128 creator A5020990675 @default.
• W4381599128 creator A5032065597 @default.
• W4381599128 creator A5047697252 @default.
• W4381599128 creator A5053933535 @default.
• W4381599128 date "2023-06-22" @default.
• W4381599128 modified "2023-10-17" @default.
• W4381599128 title "Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis" @default.
• W4381599128 cites W10273366 @default.
• W4381599128 cites W1558095504 @default.
• W4381599128 cites W1572195475 @default.
• W4381599128 cites W1596455153 @default.
• W4381599128 cites W1863298072 @default.
• W4381599128 cites W1981076220 @default.
• W4381599128 cites W1985045939 @default.
• W4381599128 cites W1985064543 @default.
• W4381599128 cites W1986011773 @default.
• W4381599128 cites W1996275701 @default.
• W4381599128 cites W2012105042 @default.
• W4381599128 cites W2015598917 @default.
• W4381599128 cites W2015619851 @default.
• W4381599128 cites W2016618265 @default.
• W4381599128 cites W2046102857 @default.
• W4381599128 cites W2065161047 @default.
• W4381599128 cites W2067430542 @default.
• W4381599128 cites W2069033266 @default.
• W4381599128 cites W2089479581 @default.
• W4381599128 cites W2098544804 @default.
• W4381599128 cites W2099773761 @default.
• W4381599128 cites W2121636280 @default.
• W4381599128 cites W2122214428 @default.
• W4381599128 cites W2129510400 @default.
• W4381599128 cites W2130266202 @default.
• W4381599128 cites W2134458441 @default.
• W4381599128 cites W2143655682 @default.
• W4381599128 cites W2156249071 @default.
• W4381599128 cites W2164058436 @default.
• W4381599128 cites W2242428766 @default.
• W4381599128 cites W2266133323 @default.
• W4381599128 cites W2408809427 @default.
• W4381599128 cites W2419283865 @default.
• W4381599128 cites W2469900738 @default.
• W4381599128 cites W2530922844 @default.
• W4381599128 cites W2889844924 @default.
• W4381599128 cites W2931561488 @default.
• W4381599128 cites W2988417862 @default.
• W4381599128 cites W3006932598 @default.
• W4381599128 cites W3021476651 @default.
• W4381599128 cites W3093644374 @default.
• W4381599128 cites W3096149391 @default.
• W4381599128 cites W3118615836 @default.
• W4381599128 cites W3192074170 @default.
• W4381599128 cites W3192502787 @default.
• W4381599128 cites W4200454723 @default.
• W4381599128 cites W4255895129 @default.
• W4381599128 cites W4256315501 @default.
• W4381599128 cites W4318774132 @default.
• W4381599128 cites W4319262265 @default.
• W4381599128 cites W4381599128 @default.
• W4381599128 doi "https://doi.org/10.1111/aogs.14617" @default.
• W4381599128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37345445" @default.
• W4381599128 hasPublicationYear "2023" @default.
• W4381599128 type Work @default.
• W4381599128 citedByCount "1" @default.
• W4381599128 countsByYear W43815991282023 @default.
• W4381599128 crossrefType "journal-article" @default.
• W4381599128 hasAuthorship W4381599128A5008499634 @default.
• W4381599128 hasAuthorship W4381599128A5018646147 @default.
• W4381599128 hasAuthorship W4381599128A5020990675 @default.
• W4381599128 hasAuthorship W4381599128A5032065597 @default.
• W4381599128 hasAuthorship W4381599128A5047697252 @default.
• W4381599128 hasAuthorship W4381599128A5053933535 @default.
• W4381599128 hasBestOaLocation W43815991281 @default.
• W4381599128 hasConcept C126322002 @default.
• W4381599128 hasConcept C131872663 @default.
• W4381599128 hasConcept C141071460 @default.
• W4381599128 hasConcept C168563851 @default.
• W4381599128 hasConcept C2775948956 @default.
• W4381599128 hasConcept C2776018949 @default.
• W4381599128 hasConcept C2779234561 @default.
• W4381599128 hasConcept C2781059491 @default.
• W4381599128 hasConcept C29456083 @default.
• W4381599128 hasConcept C3019815172 @default.
• W4381599128 hasConcept C46973012 @default.
• W4381599128 hasConcept C54355233 @default.
• W4381599128 hasConcept C71315377 @default.
• W4381599128 hasConcept C71924100 @default.
• W4381599128 hasConcept C86803240 @default.
• W4381599128 hasConcept C95190672 @default.
• W4381599128 hasConceptScore W4381599128C126322002 @default.
• W4381599128 hasConceptScore W4381599128C131872663 @default.
• W4381599128 hasConceptScore W4381599128C141071460 @default.
• W4381599128 hasConceptScore W4381599128C168563851 @default.
• W4381599128 hasConceptScore W4381599128C2775948956 @default.
• W4381599128 hasConceptScore W4381599128C2776018949 @default.

• next